Tag: business news

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

April 11, 2026 Admin No Comments

Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September 19, 2024 in London, England. Leon Neal | Getty Images News | Getty Images Once the go-to location for global drugmakers, Europe is now being squeezed by President Donald Trump’s aggressive trade and drug-pricing…

Health

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed

March 27, 2026 Admin No Comments

AstraZeneca‘s stock rose over 3% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the overall population versus placebo, the company said. “This marks a notable shift…

Health

Vertex passes key test in quest to treat kidney diseases

March 10, 2026 Admin No Comments

A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston. Brian Snyder | Reuters Vertex Pharmaceuticals said its experimental drug for a rare kidney condition succeeded in a Phase 3 trial, a crucial step in the company’s path to diversify beyond its main drugs for cystic fibrosis. The Boston-based drugmaker on…

Health

Healthy Returns: What’s next for Novo Nordisk’s next-generation obesity drug CagriSema after trial miss

February 24, 2026 Admin No Comments

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novo Nordisk isn’t catching a break this year. Shares of the Danish drugmaker plummeted on Monday after it released data showing that its next-generation obesity drug failed…

Health

Novo Nordisk sues Hims & Hers over copycat versions of Wegovy drugs; Hims stock falls 18%

February 9, 2026 Admin No Comments

Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity pill and injections in the U.S. Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe on the company’s patents and…

Health

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

January 23, 2026 Admin No Comments

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone. Top executives from drugmakers big and small told CNBC that the next phase…

Health

First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.

January 5, 2026 Admin No Comments

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Nov. 24, 2025. Tom Little | Reuters Novo Nordisk will start rolling out the first-ever GLP-1 pill for weight loss in the U.S. on Monday, the company announced, marking a new chapter of obesity…

Health

Inside the dealmaking that pushed Trump to reclassify pot, expand access

December 19, 2025 Admin No Comments

President Donald Trump‘s move Thursday to sign an executive order easing federal restrictions on marijuana — and clearing the way for a Medicare pilot program covering CBD — caps a coordinated, yearlong push by the cannabis industry that combined traditional lobbying, sizable political donations, data-driven messaging and direct outreach to the president’s inner circle, industry…

Health

RFK Jr.’s vaccine panel defers vote on hepatitis B shot for babies until Friday

December 4, 2025 Admin No Comments

Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine committee on Thursday deferred crucial votes on hepatitis B vaccines for babies until Friday, saying it will give members more time to review proposed language on the measure. One panel member, Dr. Cody Meissner, a professor of pediatrics at the Dartmouth Geisel School of…

Health

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

November 17, 2025 Admin No Comments

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump administration to…

Health